Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

June 29, 2014

Spectranetics Completes Acquisition of AngioScore

June 30, 2014—Spectranetics Corporation announced that it has completed the acquisition of AngioScore Inc., for $230 million in cash, along with additional contingent commercial and regulatory milestone payments. Plans for the acquisition were first announced on May 27, 2014.

AngioScore develops and markets the AngioSculpt scoring balloon technology platform, which is a portfolio of devices to treat blockages in the coronary and peripheral vasculature, including critical limb ischemia, in-stent restenosis, calcified lesions, and chronic total occlusions. AngioScore is based in Fremont, California. Spectranetics is headquartered in Colorado Springs, Colorado.

Advertisement

July 1, 2014

Cordis Launches Saber PTA Dilatation Catheter

left-arrow Created with Sketch. Previous Article

June 28, 2014

AAA SCORE Developed to Predict Mortality After Open and Endovascular AAA Repair

Next Article right-arrow Created with Sketch.

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button
)